Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the US Justice Department

被引：5
作者：
Curtiss, Frederic R. [1 ]
Fairman, Kathleen A. [1 ]
机构：
[1] Acad Managed Care Pharm, Alexandria, VA 22314 USA
来源：
JOURNAL OF MANAGED CARE PHARMACY | 2009年 / 15卷 / 02期
关键词：
PROMOTION; BEVACIZUMAB; GABAPENTIN; CANCER;
D O I：
10.18553/jmcp.2009.15.2.161
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：161 / 165
页数：5
相关论文
共 41 条
  • [1] ABELSON R, 2009, NY TIMES 0126
  • [2] *AG HEALTHC RES QU, 2007, TECHN ASS COMP COV O
  • [3] *AG HEALTHC RES QU, 2007, EFF HLTH CAR EFF COM
  • [4] *AG HEALTHC RES QU, 2008, NAT GUID CLEAR ASS M
  • [5] [Anonymous], WALL STREET J 0707
  • [6] ARMSTRONG D, 2003, WALL STREET J 0530, pB4
  • [7] Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
    Bach, Peter B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06) : 626 - 633
  • [8] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial
    Backonja, M
    Beydoun, A
    Edwards, KR
    Schwartz, SL
    Fonseca, V
    Hes, M
    LaMoreaux, L
    Garofalo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21): : 1831 - 1836
  • [9] *CAN AG DRUGS TECH, 2009, TECHN OV
  • [10] Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
    Cannistra, Stephen A.
    Matulonis, Ursula A.
    Penson, Richard T.
    Hambleton, Julie
    Dupont, Jakob
    Mackey, Howard
    Douglas, Jeffrey
    Burger, Robert A.
    Armstrong, Deborah
    Wenham, Robert
    McGuire, William
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5180 - 5186
12345